Pharming's Marketing Authorization Application for Rhucin -- RHC1INH -- Accepted for Review by EMEA
17. August 2006 12:58 ET
|
Pharming Group N.V.
LEIDEN, Netherlands, Aug. 17, 2006 (PRIMEZONE) -- Biotech company Pharming Group N.V. ("Pharming") (Euronext:PHARM) (PHARM.AS) announced today that its Marketing Authorization Application (MAA) for...
Pharming Presents rhC1INH Update at International Meetings
17. November 2005 02:13 ET
|
Pharming Group N.V.
LEIDEN, Netherlands, Nov. 17, 2005 (PRIMEZONE) -- Biotech company Pharming Group N.V. ("Pharming" or "the Company") (Euronext: PHARM) (PHARM.AS) announced today that the Company presented clinical...
Pharming Candidate for Amsterdam Midkap Index on Euronext
09. November 2005 02:18 ET
|
Pharming Group N.V.
LEIDEN, Netherlands, Nov. 09, 2005 (PRIMEZONE) -- Biotech company Pharming Group N.V. ("Pharming" or "the Company") (Euronext: PHARM) (PHARM.AS) announced today that it has been selected by Euronext...
Pharming Announces Results for First Nine Months 2005
03. November 2005 01:24 ET
|
Pharming Group N.V.
LEIDEN, Netherlands, Nov. 3, 2005 (PRIMEZONE) -- Highlights: upcoming product filings, licensing progress and pipeline expansion. Pharming Group N.V. ("Pharming" or "the Company") (Euronext: PHARM)...
Pharming Appoints New Head of Finance and Administration
24. Oktober 2005 01:09 ET
|
Pharming Group N.V.
LEIDEN, Netherlands, Oct. 24, 2005 (PRIMEZONE) -- Biotech company Pharming Group N.V. ("Pharming" or "the Company") (Euronext: PHARM) (PHARM.AS) announced today that it has appointed Mr. Wim J. E....
Pharming Presents Human Lactoferrin Results at International Conference
19. Oktober 2005 08:07 ET
|
Pharming Group N.V.
LEIDEN, Netherlands, Oct. 19, 2005 (PRIMEZONE) -- Biotech company Pharming Group N.V. ("Pharming" or "the Company") (Euronext: PHARM) (PHARM.AS) announced today results from three studies which...
Pharming Expands Clinical Development of Recombinant Human C1 Inhibitor for new Indications
29. September 2005 01:12 ET
|
Pharming Group N.V.
LEIDEN, Netherlands, Sept. 29, 2005 (PRIMEZONE) -- Biotech companyPharming Group N.V. ("Pharming" or "the Company") (Euronext:PHARM) (PHARM.AS) announced today that it will commence clinical...
Pharming to Present at UBS Global Life Sciences Conference
20. September 2005 01:38 ET
|
Pharming Group N.V.
LEIDEN, Netherlands, Sept. 20, 2005 (PRIMEZONE) -- Biotech company Pharming Group N.V. ("Pharming" or "the Company") (Euronext: PHARM) (PHARM.AS) announced today that the Company will present at the...
Pharming's Recombinant Human Fibrinogen Selected for U.S. Army Project
31. August 2005 02:07 ET
|
Pharming Group N.V.
LEIDEN, Netherlands, Aug. 31, 2005 (PRIMEZONE) -- Biotech company Pharming Group N.V. ("Pharming" or "the Company") (Euronext:PHARM) (PHARM.AS) announced today that its recombinant human fibrinogen...
Pharming Announces First Half 2005 Results
19. August 2005 01:48 ET
|
Pharming Group N.V.
LEIDEN, Netherlands, Aug. 19, 2005 (PRIMEZONE) -- Biotech company Pharming Group N.V. ("Pharming" or "the Company") (Euronext:PHARM) (PHARM.AS) (Other OTC:PHGUF) announced today its results for the...